TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Pelago Bioscience AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
88,724
|
78,312
|
72,008 |
Financial expenses |
16
|
51
|
16 |
Earnings before taxes |
-7,172
|
5,426
|
9,765 |
EBITDA |
-5,527
|
10,309
|
13,683 |
Total assets |
93,039
|
67,804
|
59,201 |
Current assets |
62,213
|
53,665
|
41,233 |
Current liabilities |
34,662
|
35,849
|
31,202 |
Equity capital |
58,282
|
29,579
|
25,830 |
- share capital |
116
|
51
|
53 |
Employees (average) |
52
|
51
|
39 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
62.6%
|
43.6%
![]() |
43.6% |
Turnover per employee |
1,706
|
1,536
|
1,846 |
Profit as a percentage of turnover |
-8.1%
|
6.9%
|
13.6% |
Return on assets (ROA) |
-7.7%
|
8.1%
|
16.5% |
Current ratio |
179.5%
|
149.7%
|
132.1% |
Return on equity (ROE) |
-12.3%
|
18.3%
|
37.8% |
Change turnover |
4,855
|
8,468
|
10,765 |
Change turnover % |
6%
|
12%
|
18% |
Chg. No. of employees |
1
|
12
![]() |
12 |
Chg. No. of employees % |
2%
|
31%
|
44% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.